NeuroMetrix, Inc.

NeuroMetrix is a commercial stage company that was founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology. The Company has three commercial products. DPNCheck® is a diagnostic device that provides rapid, point-of-care detection of peripheral neuropathies. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of focal neuropathies. Quell® Fibromyalgia is a wearable neurostimulation device indicated as an aid for reducing the symptoms of fibromyalgia in adults with high pain sensitivity. The Company is based in Woburn, MA. We are an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. Over 5 million people worldwide have benefited from NeuroMetrix healthcare products.